Viewing nowCombinationLinaKan Empa Tablets 10/5 mg (Empagliflozin, Linagliptin)
Linagliptin 5mg · Empagliflozin Amorphous 10mg
Tablet · Prescription medication · Combination
DongKook Pharmaceutical Co., Ltd.

MFDS item code 202501804 · Approved 2025.07.15 · Insurance code 653406080
Improvement of glycemic control in patients with type 2 diabetes mellitus
This medication helps control the blood sugar levels of patients with type 2 diabetes by using Empagliflozin and Linagliptin together. When taken in conjunction with dietary control and exercise therapy, it can help effectively manage blood sugar levels. This supports smoother diabetes management.
The recommended starting dose of this medicine is empagliflozin 10 mg/linagliptin 5 mg once daily. If empagliflozin 10 mg/linagliptin 5 mg is tolerated but additional glycemic control is needed, the dose may be increased to 25/5 mg once daily. Patients switching to this medicine from combination therapy with empagliflozin and linagliptin should receive their previous doses. This medicine may be taken with or without food. Swallow the tablet whole. If a dose is missed, take it as soon as remembered. However, if the next dose is due within 12 hours, skip the missed dose and take the next dose at the usual scheduled time. Do not take a double dose in one day. Patients with renal impairment This medicine is not recommended for improving glycemic control in patients with an estimated glomerular filtration rate (eGFR) below 45 ml/min/1.73m2. No dose adjustment is necessary in patients with an estimated glomerular filtration rate of 45 ml/min/1.73m2 or higher. Patients with hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment. Use of this medicine is not recommended in patients with severe hepatic impairment, as it has not been studied in these patients. Elderly patients No dose adjustment is necessary based on age. In patients aged 75 years or older, renal function and the risk of volume depletion should be considered.
This medication contains the ingredients Empagliflozin and Linagliptin, which aid in blood sugar control. This medication should not be administered to certain patients. For instance, it is contraindicated in individuals with an allergy to its components, patients with type 1 diabetes, those with diabetic ketoacidosis, and patients who are undergoing renal dialysis. Patients with impaired kidney function should have their kidneys regularly monitored while using this medication. It is particularly advisable to check kidney function at least once a year. Due to limited experience in patients with heart failure, this medication should be used with caution. Acute pancreatitis may occur; therefore, if symptoms such as abdominal pain arise, the use of this medication should be discontinued immediately, and a doctor should be consulted. There may be symptoms of bullous pemphigoid, such as blisters or skin rashes; if these symptoms occur, this medication should be discontinued and a specialist consulted. The most common side effect reported is urinary tract infection, and other reported side effects include hypoglycemia, pancreatitis, and hypersensitivity. Caution is especially advised when this medication is taken together with insulin or sulfonylureas due to an increased risk of hypoglycemia. Additionally, fluid volume loss may cause a decrease in blood pressure, so this medication should be used cautiously in patients with hypertension or the elderly. This medication may also increase the risk of genital fungal infections, so prompt treatment should be sought if symptoms occur. It is best to avoid using this medication during pregnancy unless specifically indicated, and breastfeeding should be discontinued if this medication is being used. Safety and efficacy have not been established for children under 18 years of age, so it is not recommended for this group. While taking this medication, caution is necessary due to the risk of hypoglycemia when driving or operating machinery. In case of overdose, seek medical care immediately for appropriate treatment. Finally, this medication should be stored out of reach of children and kept in its original container.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture. It is important to maintain a storage temperature between 1 to 30 degrees Celsius.
Yellow round film-coated double-layer tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationLinagliptin 5mg · Empagliflozin Amorphous 10mg
Tablet · Prescription medication · Combination
DongKook Pharmaceutical Co., Ltd.
CombinationLinagliptin 5mg · Empagliflozin Amorphous 25mg
Tablet · Prescription medication · Combination
Dongkuk Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.